Pseudohypoaldosteronism Type 1 (arPHA1) Treated With Sodium Polystyrene Sulfonate Pretreated Milk

نویسندگان

  • Syed Tariq Khalil
  • Erwin Cabacungan
چکیده

reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page Pseudohypoaldosteronism type (PHA) 1 is a rare disease with an incidence of 1:47 000 to 1:80 000. 1 The presentation may be confused with other neonatal endocrino-logical problems like congenital adrenal hyperplasia, hypoaldosteronism, and Barter syndrome. Type I PHA is further subdivided into 2 distinct entities. 2 The autoso-mal dominant trait (adPHA1) results from the mutations in the gene encoding mineralocorticoid receptor (NR3C2). 3 The clinical course is mild and is restricted to kidneys. Prognosis for adPHA1 form is good and spontaneous remission is observed over time. The autosomal recessive trait (arPHA1) results from mutations of the genes (SCNN1A, SCNN1B, and SCNN1G) encoding the 3 homologous alpha beta gamma subunits of the amiloride-sensitive epithelial sodium channel (ENaC). 4 This causes loss of function or a decrease in ENaC channel activity. 4 The arPHA1 not only affects kidneys but also affects colon, lung, sweat, and salivary glands. 4 Patients with arPHA1 are reported to have recurrent pulmonary infections with pseudomonas species similar to those seen in cystic fibrosis. A 7-day-old male was admitted to the neonatal intensive care unit with a day history of poor feeding, reduced urine output, and lethargy. He was born normally after a term and uneventful pregnancy, and his birth weight was 3.3 kg. He was the second child of first-degree consan-guineous parents who emigrated from Southeast Asia. There was no family history of significant illness or unexplained death. On physical examination, he was pale, lethargic, and severely dehydrated. The rest of his systemic examination was unremarkable with normal male external geni-talia. He was tachycardic and with normal blood pressure. Electrocardiogram showed wide complex ven-tricular tachycardia, which resolved after fluid resuscitation and a dose of epinephrine. Initial labs were serum sodium 127 mEq/L, serum potassium 9.3 mEq/L, serum chloride 103 mmol/L, blood urea nitrogen 25 mg/dL, and creatinine 0.53 mg/ dL; capillary blood gas: pH 7.27, PCO 2 39.7 mm Hg, HCO 3 17.7 mEq/L, base deficit −8.5 mEq/L. Newborn screen showed normal 17-OH progesterone level. Urine sodium was 439 mmol/L, and urine potassium was <2.5 mmol/L. Further laboratory studies subsequently revealed markedly elevated plasma renin (56.32 ng/ mL/h; normal range = 0.25-5.82) and serum aldosterone (323 ng/dL; 1-12 months = 2-70 ng/dL). Serum cortisol (AM), ACTH, and 17-OH progesterone were within normal …

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene

UNLABELLED Autosomal recessive pseudohypoaldosteronism type 1 (PHA1) is a rare disorder characterized by sodium wasting, failure to thrive, hyperkalemia, hypovolemia and metabolic acidosis. It is due to mutations in the amiloride-sensitive epithelial sodium channel (ENaC) and is characterized by diminished response to aldosterone. Patients may present with life-threatening hyperkalemia, which m...

متن کامل

Severe systemic type 1 pseudohypoaldosteronism: 5 years of evolution.

ype 1 pseudohypoaldosteronism (PHA-1) was first described n 1958 by Cheek and Perry.1 It is a rare syndrome of aldoserone unresponsiveness, expressed in two forms: renal HA-1 and systemic PHA-1.2,3 Renal PHA-1 results from autoomal dominant mutations in the kidney mineralocorticoid eceptor. As the mineralocorticoid resistance is limited to ne organ, the phenotype is milder and often improves sp...

متن کامل

Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia

Hyperkalemia after kidney transplantation is a common electrolyte disturbance and the risk factors are multifactorial. Pharmacotherapeutic agents for chronic management of hyperkalemia in kidney transplant patients may be relatively contraindicated or provide suboptimal efficacy. Fludrocortisone, an endogenous mineralocorticoid mimics the actions of aldosterone, hence hyperkalemia reversal. We ...

متن کامل

Hypernatremia in a patient treated with sodium polystyrene sulfonate

Severe hyperkalemia requires urgent medical attention and correction in order to prevent arrhythmic complications. Sodium polystyrene sulfonate (SPS) is a cation exchange resin commonly used in the management of hyperkalemia. A recent review raised concerns regarding its effectiveness and potential adverse effects. Hypernatremia in adults in the setting of sodium polystyrene sulfonate therapy h...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 2  شماره 

صفحات  -

تاریخ انتشار 2015